Malaysian (KLSE) Growth Pharmaceuticals & Biotech Stocks

UPDATED Jun 12, 2024

Discover Malaysian Pharmaceuticals & Biotech Growth Stocks that are on the KLSE. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

DPHARMA

Duopharma Biotech Berhad
RM1.251.6%-6.0%RM1.2bRM1.46PE26.6xE24.8%1.8%

KOTRA

Kotra Industries Berhad
RM4.33-0.9%-18.0%RM642.2mRM4.82PE14.2xE11.5%5.9%

RHONEMA

Rhone Ma Holdings Berhad
RM0.694.5%-4.8%RM152.6mn/aPE12.5xE6.1%2.9%

AHEALTH

Apex Healthcare Berhad
RM2.900.3%21.3%RM2.1bRM2.71PE5.3xE-51.2%8.6%

MGRC

Malaysian Genomics Resource Centre Berhad
RM0.411.2%-4.6%RM56.9mn/aPS5.9xn/a0%

YSPSAH

Y.S.P. Southeast Asia Holding Berhad
RM2.97-0.3%16.9%RM421.3mn/aPE10.4xn/a3.7%

PLABS

PeterLabs Holdings Berhad
RM0.200%8.1%RM55.0mn/aPE16xn/a2.0%
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.